XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,498 $ 1,923
Short-term investments 860 1,000
Accounts receivable, net (including receivables from related parties of $164 and $182 as of September 30, 2024 and March 31, 2024, respectively) 1,006 781
Contract assets (including contract assets from related parties of $55 and $22 as of September 30, 2024 and March 31, 2024, respectively) 454 336
Prepaid expenses and other current assets 246 157
Total current assets 4,064 4,197
Non-current assets:    
Property and equipment, net 291 215
Operating lease right-of-use assets 232 205
Equity investments (including investments held at fair value of $561 and $573 as of September 30, 2024 and March 31, 2024, respectively) 796 741
Goodwill 1,641 1,625
Intangible assets, net 184 152
Deferred tax assets 351 282
Non-current portion of contract assets 273 240
Other non-current assets 254 270
Total non-current assets 4,022 3,730
Total assets 8,086 7,927
Current liabilities:    
Accrued compensation and benefits 104 298
Tax liabilities 148 147
Contract liabilities (including contract liabilities from related parties of $107 and $107 as of September 30, 2024 and March 31, 2024, respectively) 218 198
Operating lease liabilities 29 27
Other current liabilities (including payables to related parties of $12 and $7 as of September 30, 2024 and March 31, 2024, respectively) 400 835
Total current liabilities 899 1,505
Non-current liabilities:    
Non-current portion of accrued compensation 21 20
Deferred tax liabilities 131 135
Non-current portion of contract liabilities 704 717
Non-current portion of operating lease liabilities 229 194
Other non-current liabilities 90 61
Total non-current liabilities 1,175 1,127
Total liabilities 2,074 2,632
Commitments and contingencies (Note 12)
Shareholders’ equity:    
Ordinary shares, $0.001 par value; 1,088 shares authorized and 1,051 shares issued and outstanding as of September 30, 2024; and 1,088 shares authorized and 1,040 shares issued and outstanding as of March 31, 2024 2 2
Additional paid-in capital 2,519 2,171
Accumulated other comprehensive income (loss) 410 371
Retained earnings 3,081 2,751
Total shareholders’ equity 6,012 5,295
Total liabilities and shareholders’ equity $ 8,086 $ 7,927